Richard Kobza

Showing 1-3 of 3 articles

Interventions for valvular disease

First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation

Toggweiler S, De Boeck B, Brinkert M, Buhmann R, Bossard M, Kobza R, Cuculi F

September 20, 2018 | 10.4244/EIJ-D-18-00440

Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation

Toggweiler S, Nissen H, Mogensen B, Cuculi F, Fallesen C, Veien K, Brinkert M, Kobza R, Rück A

December 20, 2017 | 10.4244/EIJ-D-17-00252

Coronary interventions

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold

Jamshidi P, Nyffenegger T, Sabti Z, Buset E, Toggweiler S, Kobza R, Cuculi F

April 20, 2016 | 10.4244/EIJV11I13A287

1

Latest news

State-of-the-Art on Coronary Physiology; a Mini Focus on Biostatistics; Post-TAVI Aortic Manipulation; Minimally Invasive Ventricular Reconstruction after MI

Don't miss the next #EIJCardioChat!

IVUS-guided stenting in VIV-TAVI

Optimising Physiological Endpoints of Percutaneous Coronary Intervention

New update: OPTIMIZE PCI, EXAMINATION 10 years, BIONYX 2 years, SAFE A and more

(Thanks to the support of Biotronik)

Reducing refractory angina

Ranil de Silva et al.

Discover EuroIntervention's New Author Centre

Coronary flow reserve and coronary flow capacity at a time of shifting paradigms of ischaemic heart disease

Valvular disease